71. JAMA Oncol. 2018 Jun 14. doi: 10.1001/jamaoncol.2018.1766. [Epub ahead of print]PIK3CA Mutations in Hormone Receptor-Positive Breast Cancers: PIKing Biomarkersto Inform Adjuvant Endocrine Therapy Decisions.Stearns V(1), Park BH(1).Author information: (1)The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School ofMedicine, Baltimore, Maryland.DOI: 10.1001/jamaoncol.2018.1766 PMID: 29902310 